Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry.
Marta MenicattiMarco PallecchiSilvia BuaDaniela VulloLorenzo Di Cesare MannelliCarla GhelardiniFabrizio CartaClaudiu T SupuranGianluca BartolucciPublished in: Journal of enzyme inhibition and medicinal chemistry (2018)
Rheumatoid arthritis (RA) is a chronic inflammatory disease caused by a faulty autoimmune response. Recently, it was reported that some human carbonic anhydrases (CAs) isoforms are overexpressed in inflamed synovium of RA patients. New CA inhibitors (CAIs) incorporating CA-binding moiety and the cyclooxygenase inhibitor tail (nonsteroidal anti-inflammatory drug [NSAID] type) were studied. The aim of this work is the evaluation of the chemical stability of NSAID - CAI hybrids towards spontaneous or enzymatic hydrolysis by LC-MS/MS. The analytes are isomer pairs of 6- or 7-hydroxycoumarin, their different fragment ions abundances allowed the development of a mathematical tool (LEDA) to distinguish them. LEDA reliability at ng mL-1 level was checked (>90%), being proved the effectiveness in the correct assignment of the isomer present in the sample. The hybrids resulted stable in all tested matrices allowing us to conclude that these compounds reach the target tissues unmodified, opening perspectives for their development in the treatment of inflammation.
Keyphrases
- tandem mass spectrometry
- liquid chromatography
- rheumatoid arthritis
- ultra high performance liquid chromatography
- mass spectrometry
- high performance liquid chromatography
- end stage renal disease
- simultaneous determination
- high resolution mass spectrometry
- disease activity
- gas chromatography
- oxidative stress
- endothelial cells
- anti inflammatory drugs
- chronic kidney disease
- anti inflammatory
- newly diagnosed
- gene expression
- ejection fraction
- randomized controlled trial
- solid phase extraction
- peritoneal dialysis
- photodynamic therapy
- multiple sclerosis
- high resolution
- drug induced
- hydrogen peroxide
- single molecule
- nitric oxide synthase
- ms ms
- nitric oxide
- patient reported